Literature DB >> 1528264

APC mutations occur early during colorectal tumorigenesis.

S M Powell1, N Zilz, Y Beazer-Barclay, T M Bryan, S R Hamilton, S N Thibodeau, B Vogelstein, K W Kinzler.   

Abstract

Human tumorigenesis is associated with the accumulation of mutations both in oncogenes and in tumour suppressor genes. But in no common adult cancer have the mutations that are critical in the early stages of the tumorigenic process been defined. We have attempted to determine if mutations of the APC gene play such a role in human colorectal tumours, which evolve from small benign tumours (adenomas) to larger malignant tumours (carcinomas) over the course of several decades. Here we report that sequence analysis of 41 colorectal tumours revealed that the majority of colorectal carcinomas (60%) and adenomas (63%) contained a mutated APC gene. Furthermore, the APC gene met two criteria of importance for tumour initiation. First, mutations of this gene were found in the earliest tumours that could be analysed, including adenomas as small as 0.5 cm in diameter. Second, the frequency of such mutations remained constant as tumours progressed from benign to malignant stages. These data provide strong evidence that mutations of the APC gene play a major role in the early development of colorectal neoplasms.

Entities:  

Mesh:

Year:  1992        PMID: 1528264     DOI: 10.1038/359235a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  548 in total

1.  APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and nuclear export.

Authors:  K L Neufeld; F Zhang; B R Cullen; R L White
Journal:  EMBO Rep       Date:  2000-12       Impact factor: 8.807

2.  T cell factor-activated transcription is not sufficient to induce anchorage-independent growth of epithelial cells expressing mutant beta-catenin.

Authors:  A I Barth; D B Stewart; W J Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Differences in carcinogenesis by the length of carcinogen exposure period in rat colon.

Authors:  T Endo; K Ookawa; M Tanaka; S Nakaji; S Tsuchida; K Sugawara
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

4.  Identification of dysplasia in human colonic aberrant crypt foci.

Authors:  I M Siu; T G Pretlow; S B Amini; T P Pretlow
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

5.  LIN28B promotes colon cancer progression and metastasis.

Authors:  Catrina E King; Miriam Cuatrecasas; Antoni Castells; Antonia R Sepulveda; Ju-Seog Lee; Anil K Rustgi
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

Review 6.  APC as a checkpoint gene: the beginning or the end?

Authors:  Vincent W Yang
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

7.  K-ras mutation and loss of heterozygosity at 17p with beta-catenin accumulation in intramucosal carcinoma of the ileostomy in familial adenomatous polyposis: a case report.

Authors:  Keisuke Hata; Toshiaki Watanabe; Yutaka J Kawamura; Hironori Ishigami; Takamitsu Kanazawa; Tomohiro Tada; Bin Zhao; Shinichiro Koketsu; Hirokazu Nagawa
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

Review 8.  The ins and outs of APC and beta-catenin nuclear transport.

Authors:  Beric R Henderson; Francois Fagotto
Journal:  EMBO Rep       Date:  2002-09       Impact factor: 8.807

9.  Wnt11 signaling promotes proliferation, transformation, and migration of IEC6 intestinal epithelial cells.

Authors:  Lillian Ouko; Thomas R Ziegler; Li H Gu; Leonard M Eisenberg; Vincent W Yang
Journal:  J Biol Chem       Date:  2004-04-14       Impact factor: 5.157

10.  Expressions of two adenomatous polyposis coli and E-cadherin proteins on human colorectal cancers.

Authors:  Koh Furuta; Shingo Yoshioka; Satoko Okabe; Masato Ikeda; Mihoko Oginosawa; Seiyo Ikeda; Yoshifuku Nakayama; Masahiro Kikuchi; Stanley R Hamilton
Journal:  Virchows Arch       Date:  2003-02-11       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.